Wexford Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30,000
| Closed | -$293K | – | 235 |
|
|
2023
Q3 | $293K | Hold |
30,000
| – | – | 0.06% | 152 |
|
|
2023
Q2 | $355K | Hold |
30,000
| – | – | 0.07% | 128 |
|
|
2023
Q1 | $324K | Hold |
30,000
| – | – | 0.07% | 130 |
|
|
2022
Q4 | $347K | Hold |
30,000
| – | – | 0.07% | 86 |
|
|
2022
Q3 | $448K | Sell |
30,000
-30,000
| -50% | -$448K | 0.14% | 86 |
|
|
2022
Q2 | $541 | Buy |
60,000
+40,000
| +200% | +$361 | 0.03% | 107 |
|
|
2022
Q1 | $150 | Hold |
20,000
| – | – | 0.01% | 146 |
|
|
2021
Q4 | $172 | Buy |
+20,000
| New | +$172 | 0.01% | 179 |
|
|
2021
Q2 | $162K | Hold |
20,000
| – | – | 0.02% | 157 |
|
|
2021
Q1 | $176K | Hold |
20,000
| – | – | 0.03% | 179 |
|
|
2020
Q4 | $225K | Buy |
+20,000
| New | +$225K | 0.04% | 150 |
|